Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CXCL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
EBF2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GTSF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RSU1P2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
DENND2A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NEUROD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZSCAN23 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TCEB3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C5orf15 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CYP4Z2P - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CRB1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC22A24 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
OXGR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FIBIN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MIR548F5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on